Key facts
- This page summarizes Jonathan D. Root's Form 4 filing for Edgewise Therapeutics, Inc. (EWTX).
- 1 reported transaction and 1 derivative row are listed below.
- Filing timestamp: 18 Jun 2025, 19:36.
Jonathan D. Root - 16 Jun 2025 Form 4 Insider Report for Edgewise Therapeutics, Inc. (EWTX)
- Role
- Director
- Signature
- /s/ John R. Moore Attorney-in-Fact for Jonathan Root M.D.
- Issuer symbol
- EWTX
- Transactions as of
- 16 Jun 2025
- Net transactions value
- $0
- Form type
- 4
- Filing time
- 18 Jun 2025, 19:36:27 UTC
- Previous filing
- 05 Jun 2025
- Next filing
- 08 Jul 2025
- SEC
- View on sec.gov
Key filing fact
Jonathan D. Root filed Form 4 for Edgewise Therapeutics, Inc. (EWTX) on 18 Jun 2025.
Change
- Previous filing in this sequence was filed on 05 Jun 2025.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
See Original Filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reporting Owners (1)
CIK 0001225480
Primary reporting owner
ROOT JONATHAN D
- Relationship
- Director
- Address
- C/O EDGEWISE THERAPEUTICS, INC., 1715 38TH STREET, BOULDER
- Signature
- /s/ John R. Moore Attorney-in-Fact for Jonathan Root M.D.
- Signature date
- 18 Jun 2025
Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)
EWTX
transaction
Derivative
Stock Option (Right to Buy)
Award
- Transaction value
- $0
- Shares
- +30,000
- Change %
- Price
- $0.000000
- Shares after
- 30,000
- Date
- 16 Jun 2025
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 30,000
- Exercise price
- $14.68
- Footnotes
- F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.
Explanation of Responses:
| Id | Content |
|---|---|
| F1 | 100% of the Stock Options granted on June 16, 2025 will become vested on the earlier of (i) June 16, 2026 or (ii) the business day prior to the 2026 annual meeting of stockholders. |